239 related articles for article (PubMed ID: 34105910)
1. Specific features of T- and NK-cellular immunity in chronic lymphocytic leukemia.
Pochtar EV; Lugovskaya SA; Naumova EV; Dmitrieva EA; Kostin AI; Dolgov VV
Klin Lab Diagn; 2021 Jun; 66(6):345-352. PubMed ID: 34105910
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia.
Manukyan G; Turcsanyi P; Mikulkova Z; Gabcova G; Urbanova R; Gajdos P; Smotkova Kraiczova V; Zehnalova S; Papajik T; Kriegova E
Leuk Res; 2018 Sep; 72():113-119. PubMed ID: 30149317
[TBL] [Abstract][Full Text] [Related]
4. Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia.
Solman IG; Blum LK; Hoh HY; Kipps TJ; Burger JA; Barrientos JC; O'Brien S; Mulligan SP; Kay NE; Hillmen P; Byrd JC; Lal ID; Dean JP; Mongan A
Leuk Res; 2020 Oct; 97():106432. PubMed ID: 32911375
[TBL] [Abstract][Full Text] [Related]
5. Obinutuzumab induces depletion of NK cells in patients with chronic lymphocytic leukemia.
García-Muñoz R; Aguinaga L; Feliu J; Anton-Remirez J; Jorge-Del-Val L; Casajús-Navasal A; Nebot-Villacampa MJ; Daroca-Fernandez I; Domínguez-Garrido E; Rabasa P; Panizo C
Immunotherapy; 2018 Mar; 10(6):491-499. PubMed ID: 29562857
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
7. Eight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficiencies.
Boldt A; Borte S; Fricke S; Kentouche K; Emmrich F; Borte M; Kahlenberg F; Sack U
Cytometry B Clin Cytom; 2014 May; 86(3):191-206. PubMed ID: 24488780
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic Dissection of Normal Peripheral Blood NK Associated (NKa) Subpopulations by Flow Cytometry: Morphological Features and Relationships Between Membrane NKa (CD11b, CD 16, CD56 and CD57) arid T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) Associated Determinant Expression.
Richards SJ; Scott CS
Leuk Lymphoma; 1990; 2(1-2):111-26. PubMed ID: 27456578
[TBL] [Abstract][Full Text] [Related]
9. Morphological variants of leukemic cells in B chronic lymphocytic leukemia are associated with different T cell and NK cell abnormalities.
Reyes E; Prieto A; Carrion F; Garcia-Suarez J; Esquivel F; Alvarez-Mon M
Am J Hematol; 1997 Aug; 55(4):175-82. PubMed ID: 9257876
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
11. A low blood lymphocyte count is associated with an expansion of activated cytotoxic lymphocytes in patients with B-cell chronic lymphocytic leukaemia.
Martín AP; Martín ER; García-Suárez J; Arriagada FC; del Puerto Hernandez-Fuentes M; Vilaplana JC; Alvarez-Mon Soto M
Eur J Haematol; 1997 Aug; 59(2):89-99. PubMed ID: 9293856
[TBL] [Abstract][Full Text] [Related]
12. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease.
Tötterman TH; Carlsson M; Simonsson B; Bengtsson M; Nilsson K
Blood; 1989 Aug; 74(2):786-92. PubMed ID: 2787679
[TBL] [Abstract][Full Text] [Related]
13. Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia.
Mackus WJ; Frakking FN; Grummels A; Gamadia LE; De Bree GJ; Hamann D; Van Lier RA; Van Oers MH
Blood; 2003 Aug; 102(3):1057-63. PubMed ID: 12689926
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
[TBL] [Abstract][Full Text] [Related]
15. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
16. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
17. Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemia.
Solman IG; Blum LK; Burger JA; Kipps TJ; Dean JP; James DF; Mongan A
Leuk Res; 2021 Mar; 102():106520. PubMed ID: 33611131
[TBL] [Abstract][Full Text] [Related]
18. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
[TBL] [Abstract][Full Text] [Related]
19. Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients.
Fan F; Yoo HJ; Stock S; Wang L; Liu Y; Schubert ML; Wang S; Neuber B; Hückelhoven-Krauss A; Gern U; Schmitt A; Müller-Tidow C; Dreger P; Schmitt M; Sellner L
Int J Cancer; 2021 Jan; 148(2):419-428. PubMed ID: 32683672
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
